Reblozyl

Indicated For

Myelodysplastic syndromes with ring sideroblasts, beta thalassemia, myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

About This Medication

# BMS Access Support Co-Pay Assistance Program Patient Guide: How to Get Reblozyl (luspatercept-aamt) at Low or No Cost Reblozyl (luspatercept-aamt) is an injectable medication used to treat anemia in adults with **beta thalassemia** who need regular red blood cell transfusions, and in certain patients with **myelodysplastic syndromes (MDS)**, including those with ring sideroblasts who require at least two red blood cell units per 8 weeks.[1][2] The **BMS Access Support Co-Pay Assistance Program**, offered by **Bristol Myers Squibb (BMS)**, helps **commercially insured patients** reduce out-of-pocket costs for Reblozyl to **as little as $0 per 30-day supply**, up to a program maximum benefit (typically $25,000 per year for oncology products like Reblozyl).[1][2][8] This guide explains eligibility, application steps, and support options in simple terms to help you access Reblozyl affordably. Always consult your doctor for personalized advice. ## Who Qualifies for the Program? The program is designed for patients facing high **deductibles, co-pays, or co-insurance** on Reblozyl. Key qualifications include: - **Commercial insurance** only (e.g., employer plans, marketplace insurance).[1][2] - Prescription for a qualifying BMS medication like Reblozyl. - Willingness to comply with program terms, such as not seeking reimbursement elsewhere.[3] **Patients with government insurance (Medicare, Medicaid, TRICARE) do not qualify** for co-pay help but may get referrals to independent foundations.[1][2] No specific income thresholds are listed, making it accessible to a broad range of commercially insured patients, though restrictions apply (see Terms and Conditions).[2] ## About Reblozyl (luspatercept-aamt) Reblozyl is a first-in-class **erythroid maturation agent** administered by a healthcare professional every 3 weeks via subcutaneous injection. It works by enhancing late-stage red blood cell production to reduce transfusion needs in eligible anemia patients.[1] Common side effects include fatigue, joint pain, dizziness, and increased need for iron chelation; serious risks involve blood clots or hypertension—discuss with your doctor.[1] It's typically covered under medical benefits (buy-and-bill or specialty pharmacy), and BMS Access Support can help verify coverage.[9] ## Income Eligibility Breakdown This co-pay program **does not use income thresholds**; eligibility focuses on commercial insurance and out-of-pocket costs.[1][2] However, for context: | Eligibility Factor | Details | Notes | |--------------------|---------|-------| | **Income** | No limits specified | Open to all qualifying insured patients[2] | | **Insurance Type** | Commercial only | Government insurance ineligible[1] | | **Benefit Cap** | Up to $25,000/year (oncology) | May pay $0 per dose after cap[8] | | **Household Size** | Not required | Focus on insurance verification[3] | If income-based free medication is needed, ask about the separate BMS Patient Assistance Foundation (BMSPAF), which requires income proof.[10] ## Insurance Requirements - **Eligible**: Commercially insured patients with Reblozyl coverage but high costs.[2] - **Ineligible**: Medicare Part D, Medicaid, TRICARE, or other government programs—BMS will refer you to independent charities.[1] - BMS Access Support verifies benefits, checks prior authorizations (PA), and supports appeals.[4][9] ## Step-by-Step Application Process 1. **Confirm Eligibility**: Call **1-800-861-0048** (8 AM-8 PM ET, Mon-Fri) for a benefits review. Provide insurance details.[2][3] 2. **Enroll**: Use online e-enrollment at BMSAccessSupport.com/hcp or download the form.[3][4][6] - Patient signs authorization. - Doctor completes and signs sections. 3. **Submit**: Fax to **1-888-776-2370** or e-sign via BMSeSign.com/hcp.[3][9] 4. **Activate Co-Pay Card**: Receive digitally or by mail; use at pharmacy or doctor's office.[2] 5. **Get Support**: BMS handles PA/appeals if needed.[9] Your doctor’s office often starts this—ask them to enroll you.[7] ## Timeline and Delivery - **Processing**: Varies; benefits summary sent post-enrollment. Approval often quick for co-pay cards.[4][9] - **Delivery**: Co-pay assistance applies at point-of-service (pharmacy/infusion). Medication via your provider's procurement (buy-and-bill/specialty pharmacy).[9] - Refills: Use card ongoing until cap or renewal.[2] ## Alternatives if Denied or Ineligible - **Government Insurance**: Call 1-800-861-0048 for **independent foundation referrals** (e.g., Patient Access Network, HealthWell Foundation—not guaranteed).[1] - **Free Medication**: Apply to **BMS Patient Assistance Foundation (BMSPAF.org)** for uninsured/underinsured (requires income proof, doctor info; 1-year enrollment).[8][10] - **Other Options**: State programs, 340B clinics, or generic alternatives (none for Reblozyl currently).[5] - **Appeals**: BMS assists with insurance appeals.[9] ## Disclaimer This guide is for informational purposes based on publicly available BMS program details as of 2025.[3] Eligibility, benefits, and terms can change—visit www.BMSAccessSupport.com/co-pay-financial-assistance for full Terms & Conditions.[2] BMS makes no reimbursement guarantees.[7] Not legal/medical advice; consult your healthcare provider. Program availability subject to change.[1]

Program information last verified: March 30, 2026